tiprankstipranks
Trending News
More News >
Cipher Pharmaceuticals (TSE:CPH)
TSX:CPH
Canadian Market

Cipher Pharmaceuticals (CPH) Ratios

Compare
85 Followers

Cipher Pharmaceuticals Ratios

TSE:CPH's free cash flow for Q4 2024 was $0.57. For the 2024 fiscal year, TSE:CPH's free cash flow was decreased by $ and operating cash flow was $0.03. See a summary of the company’s cash flow.
Ratios
TTM
Dec 24Dec 23Dec 22Dec 21
Liquidity Ratios
Current Ratio
4.07 9.19 4.07 2.39 2.03
Quick Ratio
3.84 8.62 3.84 2.25 1.94
Cash Ratio
3.08 7.58 3.08 1.67 0.92
Solvency Ratio
2.85 3.92 2.85 0.66 0.49
Operating Cash Flow Ratio
1.13 3.05 1.13 1.12 1.18
Short-Term Operating Cash Flow Coverage
0.00 0.00 0.00 0.00 0.00
Net Current Asset Value
$ 28.46M$ 42.76M$ 28.46M$ 16.57M$ 8.49M
Leverage Ratios
Debt-to-Assets Ratio
<0.01 <0.01 <0.01 <0.01 0.04
Debt-to-Equity Ratio
<0.01 <0.01 <0.01 0.01 0.06
Debt-to-Capital Ratio
<0.01 <0.01 <0.01 0.01 0.05
Long-Term Debt-to-Capital Ratio
0.00 0.00 0.00 0.00 0.00
Financial Leverage Ratio
1.15 1.07 1.15 1.33 1.36
Debt Service Coverage Ratio
58.42 0.00 58.42 112.59 34.83
Interest Coverage Ratio
23.89 0.00 23.89 128.49 37.76
Debt to Market Cap
0.00 0.00 0.00 0.00 0.00
Interest Debt Per Share
<0.01 0.01 <0.01 0.02 0.08
Net Debt to EBITDA
-2.38 -3.42 -2.38 -1.47 -0.54
Profitability Margins
Gross Profit Margin
80.69%80.77%80.69%83.21%85.85%
EBIT Margin
53.45%48.68%53.45%59.51%56.30%
EBITDA Margin
57.80%54.48%57.80%62.25%62.02%
Operating Profit Margin
53.62%54.48%53.62%53.87%56.44%
Pretax Profit Margin
55.52%59.92%55.52%50.40%30.25%
Net Profit Margin
128.83%96.32%128.83%35.36%21.05%
Continuous Operations Profit Margin
128.83%96.32%128.83%35.36%20.30%
Net Income Per EBT
232.04%160.74%232.04%70.15%69.60%
EBT Per EBIT
103.55%109.99%103.55%93.55%53.59%
Return on Assets (ROA)
36.10%23.69%36.10%15.02%10.27%
Return on Equity (ROE)
41.57%25.31%41.57%19.94%13.94%
Return on Capital Employed (ROCE)
17.21%14.27%17.21%30.04%35.50%
Return on Invested Capital (ROIC)
39.87%22.91%39.87%21.04%23.72%
Return on Tangible Assets
48.15%29.73%48.15%24.02%18.65%
Earnings Yield
8.75%19.15%8.75%20.84%23.06%
Efficiency Ratios
Receivables Turnover
3.04 4.16 3.04 3.30 2.34
Payables Turnover
0.97 0.88 0.97 0.66 1.86
Inventory Turnover
1.86 1.36 1.86 2.23 3.43
Fixed Asset Turnover
42.98 52.64 42.98 43.80 11.33
Asset Turnover
0.28 0.25 0.28 0.42 0.49
Working Capital Turnover Ratio
0.90 0.59 0.90 1.61 3.99
Cash Conversion Cycle
-58.67 -60.88 -58.67 -276.15 65.84
Days of Sales Outstanding
120.08 87.76 120.08 110.75 155.75
Days of Inventory Outstanding
196.76 267.49 196.76 163.48 106.50
Days of Payables Outstanding
375.51 416.13 375.51 550.37 196.41
Operating Cycle
316.85 355.25 316.85 274.23 262.25
Cash Flow Ratios
Operating Cash Flow Per Share
0.10 0.63 0.10 0.52 0.43
Free Cash Flow Per Share
0.10 0.63 0.10 0.52 0.40
CapEx Per Share
<0.01 <0.01 <0.01 0.00 0.03
Free Cash Flow to Operating Cash Flow
0.99 1.00 0.99 1.00 0.93
Dividend Paid and CapEx Coverage Ratio
130.56 111.10 130.56 0.00 15.38
Capital Expenditure Coverage Ratio
130.56 111.10 130.56 0.00 15.38
Operating Cash Flow Coverage Ratio
24.71 45.32 24.71 26.77 6.32
Operating Cash Flow to Sales Ratio
0.51 0.76 0.51 0.63 0.54
Free Cash Flow Yield
3.45%15.01%3.45%37.11%55.42%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
11.43 5.22 11.43 4.80 4.34
Price-to-Sales (P/S) Ratio
14.73 5.03 14.73 1.70 0.91
Price-to-Book (P/B) Ratio
4.75 1.32 4.75 0.96 0.60
Price-to-Free Cash Flow (P/FCF) Ratio
29.01 6.66 29.01 2.69 1.80
Price-to-Operating Cash Flow Ratio
28.79 6.65 28.79 2.69 1.69
Price-to-Earnings Growth (PEG) Ratio
-0.83 0.02 -0.83 0.07 0.10
Price-to-Fair Value
4.75 1.32 4.75 0.96 0.60
Enterprise Value Multiple
23.10 5.81 23.10 1.26 0.93
Enterprise Value
276.07M 66.94M 276.07M 17.19M 12.43M
EV to EBITDA
23.10 5.81 23.10 1.26 0.93
EV to Sales
13.35 3.16 13.35 0.78 0.58
EV to Free Cash Flow
26.31 4.19 26.31 1.24 1.14
EV to Operating Cash Flow
26.11 4.18 26.11 1.24 1.06
Tangible Book Value Per Share
0.42 2.47 0.42 0.73 0.47
Shareholders’ Equity Per Share
0.60 3.16 0.60 1.46 1.21
Tax and Other Ratios
Effective Tax Rate
-1.32 -0.61 -1.32 0.30 0.33
Revenue Per Share
0.19 0.83 0.19 0.82 0.80
Net Income Per Share
0.25 0.80 0.25 0.29 0.17
Tax Burden
2.32 1.61 2.32 0.70 0.70
Interest Burden
1.04 1.23 1.04 0.85 0.54
Research & Development to Revenue
<0.01 <0.01 <0.01 <0.01 <0.01
SG&A to Revenue
0.21 0.25 0.21 0.00 0.00
Stock-Based Compensation to Revenue
0.02 0.06 0.02 <0.01 <0.01
Income Quality
0.40 0.78 0.40 1.78 2.67
Currency in USD
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis